J Korean Med Assoc.  2014 Nov;57(11):949-956. 10.5124/jkma.2014.57.11.949.

Percutaneous left ventricular assist device: a systematic review

• Jung Y

• KMID: 1958396
• DOI: http://doi.org/10.5124/jkma.2014.57.11.949

Abstract

The percutaneous left ventricular assist device (pLVAD) was developed for short-term use in patients who require acute circulatory support. The TandemHeart system can be inserted percutaneously in the cardiac catheterization laboratory using standard insertion techniques. The objective of this review is to evaluate the safety and effectiveness of pLVAD only for the TandemHeart. The searches were conducted via electronic databases including Medline, Embase, and the Cochrane library, and 942 non-duplicate citations were retrieved. A total of 20 studies (two randomized controlled trials, one cohort study, and 17 case series) were included for this review. Two review authors independently applied the extracted data and assessed the study quality. On the basis of current data, we recommend that the pLVAD be used as a potential treatment for rescue by the mechanical management of cardiogenic shock. On the other hand, the prophylactic use of the pLVAD requires more evidence from larger more effectively designed studies.

Keyword

Heart-assist devices; Hemodynamics; Percutaneous coronary intervention; Shock, cardiogenic

MeSH Terms

Cardiac Catheterization
Cardiac Catheters
Cohort Studies
Hand
Heart-Assist Devices*
Hemodynamics
Humans
Percutaneous Coronary Intervention
Shock, Cardiogenic

Figure

• 

  Figure 1 Diagrams of percutaneous left ventricular assist devices. (A) TandemHeart and (B) Impella (From Thiele H, et al. Eur Heart J 2007;28:2057-2063, with permission from Oxford University Press) [3].

• 

  Figure 2 Flowchart of literature selection process.

Reference

1. Chang BC. Ventricular assist devices and total artificial heart. In : Chung N, editor. Cardiovascular update. Seoul: CMPMedica Korea;2007. p. 29–35.

2. Choi JO. Treatment of advanced heart failure: beyond medical treatment. Korean J Med. 2012; 82:658–666.

3. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2007; 28:2057–2063.

4. Naidu SS. Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support. Circulation. 2011; 123:533–543.

5. Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist devices: clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010; 24:478–486.

6. Windecker S. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock. Curr Opin Crit Care. 2007; 13:521–527.

7. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62:1006–1012.

8. Scottish Intercollegiate Guidelines Network. Methodology checklists [Internet]. Edinburgh: Scottish Intercollegiate Guidelines Network;2011. cited 2014 Oct 17. Available from: http://www.sign.ac.uk/methodology/checklists.html.

9. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152:469.e1–469.e8.

10. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26:1276–1283.

11. Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra S. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace. 2012; 14:709–714.

12. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011; 57:688–696.

13. Brinkman WT, Rosenthal JE, Eichhorn E, Dewey TM, Magee MJ, Savor DS, Riley AG, Prince SL, Worley CM, Herbert MA, Mack MJ. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg. 2009; 88:1462–1466.

14. Gregoric ID, Loyalka P, Radovancevic R, Jovic Z, Frazier OH, Kar B. TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg. 2009; 88:1822–1826.

15. Bruckner BA, Jacob LP, Gregoric ID, Loyalka P, Kar B, Cohn WE, La Francesca S, Radovancevic B, Frazier OH. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J. 2008; 35:447–450.

16. Gregoric ID, Jacob LP, La Francesca S, Bruckner BA, Cohn WE, Loyalka P, Kar B, Frazier OH. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J. 2008; 35:125–129.

17. Idelchik GM, Simpson L, Civitello AB, Loyalka P, Gregoric ID, Delgado R 3rd, Kar B. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008; 27:106–111.

18. Pitsis AA, Visouli AN, Burkhoff D, Dardas P, Mezilis N, Bougioukas G, Filippatos G. Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery. Ann Thorac Surg. 2007; 84:1993–1999.

19. Burkhoff D, O'Neill W, Brunckhorst C, Letts D, Lasorda D, Cohen HA. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv. 2006; 68:211–217.

20. Kar B, Forrester M, Gemmato C, Civitello A, Loyalka P, Myers T, Reynolds D. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006; 18:93–96.

21. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001; 104:2917–2922.

22. Alli OO, Singh IM, Holmes DR Jr, Pulido JN, Park SJ, Rihal CS. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience. Catheter Cardiovasc Interv. 2012; 80:728–734.

23. Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol. 2011; 23:417–424.

24. Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Catheter Cardiovasc Interv. 2009; 74:302–310.

25. Al-Husami W, Yturralde F, Mohanty G, Pastore C, Lotun K, Venesy D, Waxman S, Pyne C, Gossman D, Nesto R, Piemonte T. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2008; 20:319–322.

26. Gimelli G, Wolff MR. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience. J Invasive Cardiol. 2008; 20:642–646.

27. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008; 20:67–72.

28. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW. The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions: the six-year Rotterdam experience. EuroIntervention. 2008; 4:331–337.